EP0850089A1 - Intrastromal photo-refractive keratectomy - Google Patents
Intrastromal photo-refractive keratectomyInfo
- Publication number
- EP0850089A1 EP0850089A1 EP96928030A EP96928030A EP0850089A1 EP 0850089 A1 EP0850089 A1 EP 0850089A1 EP 96928030 A EP96928030 A EP 96928030A EP 96928030 A EP96928030 A EP 96928030A EP 0850089 A1 EP0850089 A1 EP 0850089A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- cavity layer
- focal
- εaid
- laser beam
- eye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F9/00825—Methods or devices for eye surgery using laser for photodisruption
- A61F9/00827—Refractive correction, e.g. lenticle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
- A61F2009/00872—Cornea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/008—Methods or devices for eye surgery using laser
- A61F2009/00897—Scanning mechanisms or algorithms
Definitions
- the present invention pertains to methods for using lasers to accomplish ophthalmic surgery. More particularly, the present invention pertains to methods for reshaping the cornea of the eye to improve a patient's vision.
- the present invention is particularly, but not exclusively, useful as a method for intrastromal photorefractive keratectomy (ISPRK) .
- the cornea of an eye can, in certain instances, be surgically reshaped to correct and improve vision.
- the condition being corrected is myopia, or near-sightedness
- the cornea is relatively flattened
- hyperopia is being corrected
- the cornea is relatively steepened.
- the types of procedures may vary, the ultimate object in correcting myopia, for example, is the same. Namely, the object is to cause the anterior surface of the cornea to be flattened, usually by reducing the center thickness so that it properly refracts light entering the eye for subsequent focussing on the retina of the eye.
- the most common surgical operation for reshaping the cornea is a procedure known as radial keratotomy.
- This procedure which is used primarily to correct myopia, is performed by making a series of radial incisions on the surface of the cornea. These incisions extend from the outer edge of the cornea toward its center in spoke-like fashion to weaken selected sections of the cornea. With these weakened sections, the fluid pressure of the aqueous humor inside the eye will cause the cornea to deform.
- the desired deformation is a flattening of the cornea to provide proper light refraction for improved vision.
- U.S. Patent No. 4,665,913 which issued to L'Esperance, Jr. for an invention entitled “Method for Ophthalmological Surgery” discloses a corneal reshaping procedure using an excimer laser.
- U.S. Patent No. 4,907,586 which issued to Bille et al. for an invention entitled “Method for Reshaping the Eye", and which is assigned to the same assignee as the present invention, discloses a corneal reshaping procedure which uses a pulsed laser beam.
- the removal of tissue from the anterior surface requires photoablation of several layers of different types of tissues in the cornea. These include portions of the epithelium. Bowman's membrane and the stroma.
- the present invention recognizes that it is preferable to leave the epithelium and Bowman's membrane intact, and to limit the tissue removal to only the stroma. Removal of tissue from the stroma results in the creation of a specially shaped cavity in the stroma layer of the cornea. When the cornea deforms in the intended manner, the desired flattening of the cornea results.
- the present invention recognizes that internal tissue photoablation, or more precisely "photodisruption", can be effectively accomplished using a pulsed laser energy if the irradiance of the beam, its focal spot size, and the proper layering of photo disruption sites are effectively controlled.
- Another object of the present invention is to provide a method for intrastromal photorefractive keratectomy which controls the spot size and spot configuration of the laser beam to permit removal of stromal tissue by contiguous photodisruption at successively adjacent spots.
- Still another object of the present invention is to provide a method for intrastromal photodisruption which removes stromal tissue in a predetermined pattern of properly sized and shaped layers to attain the desired flattening of the cornea.
- Yet another object of the present invention is to provide a method for intrastromal photodisruption which is relatively easy to perform and which is comparatively cost effective.
- a method for performing photodisruption and removal of tissue limited to the stroma in the cornea of an eye uses a pulsed laser beam which is sequentially focused to individual spots at a plurality of points in the stroma. Each focus spot has a finite volume, rather than being a single point. Photodisruption of stromal tissue occurs at each spot where the beam is focused, and the volume of stromal tissue disrupted at each spot is approximately equal to the volume of the spot. The photodisrupted tissue is absorbed into or removed from the cornea through well known means.
- the spots are arranged in successive spiral patterns to photodisrupt and remove a plurality of layers of stromal tissue, with the diameters of the layers being properly sized to result in the desired diopter correction.
- the physical characteristics of the laser beam, as well as the manner of focussing the laser beam, are important to the proper performance of the method of the present invention. As indicated above, these considerations are interrelated. First, insofar as the characteristics of the laser beam are concerned, several factors are important.
- the laser beam should have a wavelength that allows the light to pass through the cornea without absorption by the corneal tissue. Accordingly, the light in the laser beam will not be absorbed as the beam transits through the cornea until it reaches the focal spot.
- the wavelength should be in the range of 0.3 micrometer ( ⁇ m) to 3 ⁇ m, with a wavelength of 1053 nanometers (nm) being preferred.
- the irradiance of the beam for accomplishment of photodisruption of stromal tissue at the focal spot should be greater than the threshold for optical breakdown of the tissue.
- the irradiance which will cause optical breakdown of stromal tissue is approximately 200 GW/cm 2 .
- the irradiance preferably should not be more than ten times greater than the threshold for optical breakdown and, in any event, not more than one hundred times greater than the threshold.
- the pulse repetition frequency of the pulsed laser beam is preferably in the range of approximately 1 to 10 kHz.
- spot size, spot configuration, and spot pattern are all important.
- the spot size of the focused laser beam should be small enough to achieve optical breakdown ' of stromal tissue at the focal spot. Typically, this requires the spot size to be approximately lO ⁇ m in diameter. Additionally, it is preferable that the spot configuration be as close to spherical as possible. To achieve this configuration for the spot it is necessary that the laser beam be focused from a relatively wide cone angle. For the present invention, the cone angle will preferably be in the range of 15° to 45°. Finally, the spots must be arranged in a pattern that is optimal for creating a cavity of the desired shape. The subsequent deformation of the cavity results in the ultimate reshaping of the cornea in the desired fashion to achieve a desired refractive effect.
- the laser beam is focused at a first selected spot at a starting point in the stroma.
- the starting point is preferably on the optical axis of the eye at a location behind the epithelium.
- the laser beam is then activated and stromal tissue at the fir ⁇ t spot is photodisrupted.
- spot size and configuration and the irradiance level of the laser beam are closely controlled for the present invention, the volume of stromal tissue which is photodisrupted and removed at the focal spot is carefully controlled.
- this volume is about the same as the volume occupied by the focal spot, or typically about a lO ⁇ m diameter spherical volume.
- the laser beam is focused at a second selected spot in the stroma.
- the second spot lies in a plane containing the first focal spot, with the plane being perpendicular to the optical axis of the eye. It should be noted, however, that during photodisruption of the stromal tissue, a cavitation bubble results which has a diameter which is up to about twice the diameter of the focal spot. Therefore, the second focal spot is selected at a point in the stroma which is substantially adjacent to the cavitation bubble resulting from the first focal spot.
- the laser beam is activated and stromal tissue at the second spot is photodisrupted to add to the volume of stromal tissue which had previously been photodisrupted. Because of the placement of the second spot relative to the cavitation bubble from the first spot, there is some overlap between the cavitation bubbles at the two spots. This process is continued, proceeding from point to point along a planar spiral through the stroma, until a lO ⁇ m thick layer of stromal tissue has been photodisrupted and removed. The layer of photodisrupted tissue is perpendicular to the optical axis.
- tissue photodisruption be accomplished at a plurality of adjacent points in a patterned sequence to create a plurality of layers of tissue removal.
- the object is to create a dome shaped cavity within the stromal tissue.
- the dome shaped cavity subsequently collapses, reshaping the corneal surface.
- the present invention contemplates that the adjacent focal spots in a given layer of the stroma are all located in a plane perpendicular to the optical axis of the eye, and that the pattern of spots in each layer is a spiral pattern which is substantially centro-symmetric to the optical axis of the eye.
- a plurality of superposed photodisrupted layers can be created by first photodisrupting the layer which is to be farthest from the epithelium, followed by successive photodisruption of additional layers in an anterior progression. Each successive layer in the anterior progression has a smaller diameter than the previous layer. The amount by which each layer is smaller than the previous one is determined by a particular geometric model which has been devised to result in the creation of the desired dome shaped cavity. Regardless of the number of layers created, it is important that every layer be at a safe distance from the epithelium, e.g. no closer than approximately 30 ⁇ m.
- Figure l is a cross sectional view of the cornea of an eye shown in relationship to a schematically depicted laser unit;
- Figure 2 is a cross sectional view of the cornea of an eye showing the anatomical layers thereof;
- Figure 3 is a schematic representation of the relative positioning of adjacent laser beam spots and the resultant overlapping disruption of stromal tissue which occurs during implementation of the method of the present invention;
- Figure 4 is a plan view schematic representation of a predetermined spiral pattern of focal spots and the resultant layer in which stromal tissue is photodisrupted by implementation of the method of the present invention.
- a cross section of part of an eye is shown and generally designated 10.
- the portion of eye 10 which is shown includes the cornea 12, the sclera 14 and the lens 16.
- the z-axis or z direction is generally oriented on the optical axis of the eye " 10. Consequently, the x and y directions establish a plane which is generally perpendicular to the optical axis.
- the anatomy of the cornea 12 of an eye 10 includes five different identifiable tissues.
- the epithelium 18 is the outermost tissue on the exterior of the cornea 12.
- Bowman's membrane 20 Behind the epithelium 18, and ordered in a posterior direction along the z-axis, are Bowman's membrane 20, the stroma 22, Descemet's membrane 24, and the endothelium 26. Of these various tissues, the region of most interest to the present invention is the stroma 22.
- the method of the present invention incorporates a laser unit 28 which must be capable of generating a pulsed laser beam 30 having certain characteristics.
- the pulsed laser beam 30 should be monochromatic light having a wavelength ( ⁇ ) which will pass through all tissues of the cornea 12 without interacting with those tissues.
- the pulse repetition rate of laser beam 30 should be approximately in the range of from one hundred Hertz to one hundred thousand Hertz (0.1-100 kHz).
- irradiance of laser beam 30 must be circumscribed and well defined.
- the main concern here is that the irradiance of beam 30 will, in large part, determine the photodisruptive capability of pulsed laser beam 30 on tissue of the stroma 22.
- Irradiance or radiant flux density
- the irradiance of laser beam 30 is a function of several variables. Specifically:
- Irradiance (pu ⁇ ⁇ e d uration) (spot size)
- irradiance is proportional to the amount of energy in each pulse of beam 30.
- irradiance is inversely proportional to pulse duration and spot size.
- the significance of this functional relationship stems from the fact that the irradiance of pulsed laser 30 should be approximately equal to the optical breakdown threshold for stromal tissue 22. This threshold is known to be about two hundred gigawatts per square centimeter (200 GW/cm 2 ) . Insofar as each factor's contribution to irradiance is concerned, it is important to recognize that no one factor can be considered individually. Instead, the pulse energy, pulse duration and focal spot size of laser beam 30 are interrelated, and each characteristic is variable.
- the pulse duration of pulses in laser beam 30 is preferably in the range of from one hundred femtoseconds to ten nanoseconds, and preferably in the range of one to one hundred pico seconds (1-100 psec) .
- the spot size to which each pulse is focused the determinative consideration is that the spot size should be small enough to achieve optical breakdown in a volume of stromal tissue 22 which is approximately equal to the volume of the focal spot. This relationship is perhaps best seen in Figure 3.
- FIG 3 a succession of focal spots 32a-f are shown. All focal spots 32a-f are substantially spherical, or slightly ellipsoidal, and have substantially the same volume. As such, they can each be characterized as having a diameter 34.
- Focal spots 32a-f are shown arranged in a straight line 50 for the sake of simplicity of the drawing, but as will be explained, for the present invention, it is preferable for the focal spots 32a-f to be arranged on a spiral path.
- Figure 3 also shows the general relationship between each focal spot 32a-f and the associated cavitation bubble 36a-f which results when laser unit 28 is activated to irradiate a focal spot 32a-f.
- the cavitation bubble 36a-f like the associated focal spot 32a-f, will be generally spherical and can be characterized by a diameter 38. As indicated above, it is preferable that diameter 38 of each of cavitation bubbles 36a-f be the same as the diameter 34 of the corresponding focal spot 32a-f. This, however, cannot always be achieved. In any event, it is important that the volume of cavitation bubble 36a-f not be significantly larger than the volume of the focal spot 32a- f. For the present invention, it is important that the diameter 34 of focal spots 32a-f be less than about one hundred microns (lOO ⁇ m) , and preferably about lO ⁇ m.
- the diameter 38 of cavitation bubbles 36a-f be no more than about twice the diameter 34 of focal spots 32a-f.
- the focal spot 32a-f is substantially spherical.
- cone angle 40 should be in the range of from fifteen to forty five degrees (15°-45°) .
- the best results are known to be achieved with a cone angle of about thirty six degrees (36°) .
- laser beam 30 is focused on a focal spot 32a at a first selected focal point 42a in the stroma 22.
- the first focal point 42a is located generally on the z-axis 44 behind the Bowman's membrane 20.
- "behind” means in a posterior direction or inwardly from the Bowman's membrane.
- the laser beam 30 is repositioned for refocussing at another point 42b.
- the second focal point 42b is substantially adjacent to first focal point 42a and that both the second focal point 42b and first focal point 42a lie on a path 50.
- the distance along path 50 between first focal point 42a and second focal point 42b is selected so that the adjacent volumes of disrupted tissue in cavitation bubbles 36a,b will overlap.
- the size of the cavitation bubbles 36a-f of disrupted tissue volume will determine the separation distance between selected focal points 42a-f along the path 50.
- subsequent focal points 42c et seq will be selected so that subsequent focal points 42c et seq.
- Figure 4 shows a plan view of a photodisrupted layer 52 as seen looking toward the eye 10 along z-axis 44. Also, Figure 4 shows that the first focal point 42a and the sequence of subsequent points 42b-f all lie along the path 50. Further, Figure 4 shows that the path 50 can be set as a pattern 62 and, as shown in Figure 4, this pattern 62 can be a spiral pattern. It is to be appreciated that the spiral pattern 62 can be extended as far as is desired and necessary to create the layer 52 of disrupted tissue volumes 36. Further, it is to be appreciated that layer 52 may be curved to generally conform to the shape of the cornea's external surface. It is also to be appreciated that the final pattern 62 will, be approximately centro- symmetric with respect to the optical axis (z-axis 44) of the eye 10.
- a plurality of disrupted tissue volumes 36 can be juxtaposed to establish a continuous layer 52 of disrupted stromal tissue. Only a few of the disrupted tissue volumes 36 are shown in layer 52, for the sake of clarity of the drawing, but it should be understood that the entire layer 52 is disrupted as discussed above.
- a plurality of layers can be created in stroma 22 by the method of the present invention.
- Figure 2 shows a layer 54 which is located in front of the layer 52 and a layer 56 which is located in front of the layer 54.
- Layers 58 and 60 are also shown, with layer 60 being the most anterior and smallest in diameter.
- layers 54, 56, 58, and 60 are entirely created by a plurality of disrupted tissue volumes 36. At least ten of these layers can be so created, if desired.
- layers 52, 54, 56, 58, and 60 it is necessary to start first with the creation of the layer 52. Then, in order, layers 54, 56, 58, and 60 can be created.
- a change in corneal curvature is accomplished by removing certain layers of the stromal tis ⁇ ue to create a dome shaped cavity entirely within the stromal layer 22. This cavity will then collapse, resulting in a flattening of the corneal anterior surface. This flattening will achieve the de ⁇ ired corneal curvature change.
- the de ⁇ ired corneal curvature change D in diopters can be computed according to the following equation:
- N is the selected number of intrastromal layers to be used to achieve the curvature change.
- the thicknes ⁇ of each layer, such as lO ⁇ m in the example given, is represented by t.
- the index of refraction of the cornea is 5 represented by n .
- the corneal radius of curvature is p, with ⁇ 0 being the preoperative radius.
- the appropriate diameter for each layer, d ⁇ , to achieve a desired correction of the anterior corneal curvature is calculated according to the following equation:
- Table 1 lists the layer diameters, in millimeters, which would result from the selection of an outer treatment zone diameter, or cavity diameter, of 6 mm. , where N, the number of intrastromal layer ⁇ , varie ⁇ from 2 to 10.
- the first layer ha ⁇ the ⁇ ame diameter as the treatment zone.
- the preoperative corneal radius of curvature is as ⁇ umed to be 8 mm.
- each layer is assumed to have a thicknes ⁇ of 10 ⁇ m.
- the expected re ⁇ ultant change in corneal radiu ⁇ of curvature is listed at the bottom of each column.
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Optics & Photonics (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Laser Surgery Devices (AREA)
Abstract
Description
Claims
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51658195A | 1995-08-17 | 1995-08-17 | |
US516581 | 1995-08-17 | ||
PCT/US1996/012556 WO1997006856A1 (en) | 1995-08-17 | 1996-07-30 | Intrastromal photo-refractive keratectomy |
CA002226949A CA2226949C (en) | 1995-08-17 | 1998-02-16 | Intrastromal photo-refractive keratectomy |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0850089A1 true EP0850089A1 (en) | 1998-07-01 |
EP0850089A4 EP0850089A4 (en) | 2000-04-12 |
Family
ID=31947233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96928030A Withdrawn EP0850089A4 (en) | 1995-08-17 | 1996-07-30 | Intrastromal photo-refractive keratectomy |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0850089A4 (en) |
JP (1) | JPH11511051A (en) |
CA (1) | CA2226949C (en) |
WO (1) | WO1997006856A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5993438A (en) * | 1993-11-12 | 1999-11-30 | Escalon Medical Corporation | Intrastromal photorefractive keratectomy |
DE10334108B4 (en) * | 2003-07-25 | 2018-05-09 | Carl Zeiss Meditec Ag | Apparatus for forming a closed, curved cut surface |
US10588694B1 (en) | 2007-01-19 | 2020-03-17 | Joseph Neev | Devices and methods for generation of subsurface micro-disruptions for biomedical applications |
US10543123B2 (en) | 2008-04-28 | 2020-01-28 | Joseph Neev | Devices and methods for generation of subsurface micro-disruptions for opthalmic surgery and opthalmic applications |
DE102019122167A1 (en) * | 2019-08-19 | 2021-02-25 | Schwind Eye-Tech-Solutions Gmbh | Method for controlling an ophthalmic laser and treatment device |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4907586A (en) * | 1988-03-31 | 1990-03-13 | Intelligent Surgical Lasers | Method for reshaping the eye |
EP0657151A1 (en) * | 1993-11-12 | 1995-06-14 | Intelligent Surgical Lasers, Inc. | Intrastromal photorefractive keratectomy |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4903695C1 (en) * | 1988-11-30 | 2001-09-11 | Lri L P | Method and apparatus for performing a keratomileusis or the like operation |
WO1994009849A1 (en) * | 1992-10-26 | 1994-05-11 | Swinger Casimir A | Method of performing ophthalmic surgery |
-
1996
- 1996-07-30 EP EP96928030A patent/EP0850089A4/en not_active Withdrawn
- 1996-07-30 WO PCT/US1996/012556 patent/WO1997006856A1/en not_active Application Discontinuation
- 1996-07-30 JP JP9509310A patent/JPH11511051A/en not_active Ceased
-
1998
- 1998-02-16 CA CA002226949A patent/CA2226949C/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4907586A (en) * | 1988-03-31 | 1990-03-13 | Intelligent Surgical Lasers | Method for reshaping the eye |
EP0657151A1 (en) * | 1993-11-12 | 1995-06-14 | Intelligent Surgical Lasers, Inc. | Intrastromal photorefractive keratectomy |
Non-Patent Citations (1)
Title |
---|
See also references of WO9706856A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2226949A1 (en) | 1999-08-16 |
JPH11511051A (en) | 1999-09-28 |
CA2226949C (en) | 2009-05-05 |
WO1997006856A1 (en) | 1997-02-27 |
EP0850089A4 (en) | 2000-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5993438A (en) | Intrastromal photorefractive keratectomy | |
US20210121323A1 (en) | Device and method for producing control data for the surgical correction of the defective eye vision | |
EP1487368B1 (en) | System for improved material processing using a laser beam | |
US5613965A (en) | Corneal reprofiling using an annular beam of ablative radiation | |
EP1631223B1 (en) | Apparatus for ophthalmologic surgical procedures using a femtosecond fiber laser | |
US5411501A (en) | Laser reprofiling system for correction of astigmatisms | |
WO1994009849A1 (en) | Method of performing ophthalmic surgery | |
US6063072A (en) | Methods and systems for correction of hyperopia and/or astigmatism using ablative radiation | |
CA2127029C (en) | Intrastromal photorefractive keratectomy | |
CA2226949C (en) | Intrastromal photo-refractive keratectomy | |
EP0654985B1 (en) | Laser reprofiling system for correction of astigmatisms | |
EP1941849B1 (en) | Apparatus for corneal laser surgery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19980317 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): DE FR GB |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: BILLE, JOSEF, F. Inventor name: JUHASZ, TIBOR |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20000229 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): DE FR GB |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61N 5/02 A, 7A 61F 9/00 B |
|
17Q | First examination report despatched |
Effective date: 20000623 |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20030715 |